Donecopride is a dual-acting small molecule functioning as a 5-HT4 receptor partial agonist and a selective AChE inhibitor. It promotes sAPP-alpha release in vitro and demonstrates in vivo efficacy in Alzheimers disease mouse models by reducing amyloid-beta levels and improving cognitive performance in behavioral tests like NOR and Y-maze.
Target-Kategorie:
Others
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
